<!doctype html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no" name="viewport">
  <meta name="format-detection" content="telephone=no">

 <!-- <META HTTP-EQUIV="pragma" CONTENT="no-cache">
  <META HTTP-EQUIV="Cache-Control" CONTENT="no-cache, must-revalidate">
  <META HTTP-EQUIV="expires" CONTENT="0">-->
  
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<link rel="shortcut icon" href="https://www.qimingvc.com/sites/default/files/favicon_1.ico" type="image/vnd.microsoft.icon" />
<meta name="description" content="Qiming Venture Partners is a top-tier VC firm with outstanding reputation. With our exceptional investment performances, we have been widely recognized by investors from around the world.We have a reputation for being entrepreneur friendly." />
<meta name="keywords" content="qiming ventures, qiming venture partners, qiming, healthcare, 启明创投, 启明, 风险投资, TMT, 医疗健康" />
<meta name="robots" content="follow, index" />
<meta name="generator" content="TUYI (http://www.tuyidesign.com)" />
<link rel="image_src" href="http://www.qimingvc.com/sites/all/themes/qiming/images/logo.svg" />
<link rel="canonical" href="https://www.qimingvc.com/en/node/2892/http%3A/sites/all/themes/qiming/images/logo.svg" />
<link rel="shortlink" href="https://www.qimingvc.com/en/node/2892/http%3A/sites/all/themes/qiming/images/logo.svg" />
  <title>管理金额超千亿，近两年投资生物技术企业最多的8家投资机构 | Qiming Venture Partners</title>
    <link type="text/css" rel="stylesheet" href="https://www.qimingvc.com/sites/default/files/css/css_xE-rWrJf-fncB6ztZfd2huxqgxu4WO-qwma6Xer30m4.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.qimingvc.com/sites/default/files/css/css_WkA3l5PABYsmAT6RuP_eKPA5CHBuLYSgAnfF-uTAwZI.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.qimingvc.com/sites/default/files/css/css_W2kp5XFLy3cDWCei6IzZoAAfW7H3JLbjygEbhDg6HQ4.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.qimingvc.com/sites/default/files/css/css_nfcPyOFO9FMlFbG4Nruw2C2q0-DxKGgPUF8w_nw-JF0.css" media="all" />

<!--[if lt IE 9]>
<link type="text/css" rel="stylesheet" href="https://www.qimingvc.com/sites/all/themes/qiming/css/ie.css?t5ags3" media="all" />
<![endif]-->
<link type="text/css" rel="stylesheet" href="https://www.qimingvc.com/sites/default/files/css/css_6bbUhaD_i6j4vDXTbDZ-b2jKrvhk0SBLGDi4bC17XT4.css" media="all" />
</head>
<body class="html not-front not-logged-in no-sidebars page-node page-node- page-node-2892 page-node-http page-node-http-sites page-node-http-sites-all page-node-http-sites-all-themes page-node-http-sites-all-themes-qiming page-node-http-sites-all-themes-qiming-images page-node-http-sites-all-themes-qiming-images-logosvg node-type-news i18n-en en" >
    <!--<div class="open-screen">
    <video src="images/1.mp4" id="openScreenVideo" autoplay="autoplay" muted="muted"></video>
</div>-->

<div class="header">
    <div class="w clearfix">
                    <div class="logo">
                <a href="/en" title="Qiming Venture Partners" rel="home" id="logo">
                    <img src="/sites/all/themes/qiming/images/logo.svg"
                         alt="Qiming Venture Partners"/>
                </a>
            </div>
                <div class="nav-btn">
            <span></span>
        </div>
                    <div class="lang-box">
                    <div id="block-locale-language" class="block block-locale">

    
    <ul class="language-switcher-locale-url"><li class="zh-hans first"><a href="/cn/node/2892/http%3A/sites/all/themes/qiming/images/logo.svg" class="language-link" xml:lang="zh-hans">中</a></li>
<li class="en last active"><a href="/en/node/2892/http%3A/sites/all/themes/qiming/images/logo.svg" class="language-link active" xml:lang="en">EN</a></li>
</ul></div>
            </div>
        
                    <div class="nav">
                    <div id="block-system-main-menu" class="block block-system block-menu">

    
    <ul class="menu clearfix"><li class="first leaf"><a href="/en/team">Team</a></li>
<li class="leaf"><a href="/en/portfolio">Portfolio</a></li>
<li class="leaf"><a href="/en/insights">Insights</a></li>
<li class="leaf"><a href="/en/newsroom">Newsroom</a></li>
<li class="last leaf"><a href="/en/about">About Us</a></li>
</ul></div>
            </div>
            </div>
</div>
    <div class="node-wrapper">
        <div class="w">
                                                    <div class="tabs"></div>                                </div>
                        <div id="block-system-main" class="block block-system">

    
    <div class="news-detail news-detail-2892">
    <div class="w clearfix">
        <div class="news-detail-main">
            <!--            <div class="back" data-referer="--><!--"><a href="--><!--">&nbsp;</a></div>-->
            <div class="back"><a href="javascript:history.back();">&nbsp;</a></div>
            <div class="news-type">Qiming News</div>

            <!--<a href="" class="news-type"></a>-->
            <h2 class="font-medium">管理金额超千亿，近两年投资生物技术企业最多的8家投资机构</h2>
            <div class="news-source">
                  
          <span class="date-display-single">02/08/2017</span>    
                      |   
          易企说    
                            </div>
            <div class="news-main">
                  
          <div><div class="news-group" readability="48"><p align="left" class="news002">医药行业因为高投资回报率，一直是投资机构关注的重点，2016年进行医药投资的机构数量达到226家。</p><p align="justify">每一家投资机构都有其偏好的投资领域和投资阶段，本文就盘点下2016年起，投资生物技术企业最多的8家投资机构。</p><p><strong>启明创投</strong></p><p><img height="263" src="/sites/default/files/images/news/20170802-6.jpg" width="640" /></p><p align="justify">成立于2006年的启明创投，现旗下管理有五支美元基金、四支人民币基金，管理资产总额达27亿美元。专注于投资互联网消费、医疗健康、信息技术以及清洁环保技术等早期和成长期的优秀企业。</p><p align="justify">生物医药领域是启明创投比较重视的领域。据不完全统计，从2016年起，启明创投投资生物技术企业有6家。</p><p align="center"><img height="672" src="/sites/default/files/images/news/20170802-7.jpg" width="404" /></p><p align="justify">覆盖的领域包括抗肿瘤药物、抗病毒、体外诊断等，所投企业产品及服务包括单克隆抗体、小分子靶向药、抗病毒创新药、基因检测服务等。</p><p align="center"><img height="466" src="/sites/default/files/images/news/20170802-7.png" width="712" /></p><p align="justify">元禾原点是苏州元禾控股集团（Oriza Holdings）旗下专注早期的股权投资平台。元禾控股前身即业界知名的苏州创投集团，是一家资产规模过百亿元，管理基金规模超过220亿元的投资控股企业。</p><p align="justify">元禾控股自2001年成立起就专注于股权投资领域，旗下汇集多家管理团队专注于不同的投资阶段和领域。 截至2017年3月底，共投资种子期项目333个，成长期项目98个，成熟期项目49个；完成并购投资7个；共投资子基金54支；投资项目中有55家企业已上市或过会。</p><p align="justify">从2016年起，元禾原点投资生物技术企业有6家。</p><p align="center"><img height="678" src="/sites/default/files/images/news/20170802-8.png" width="510" /></p><p align="justify">领域覆盖抗肿瘤、抗病毒、医疗器械CRO等，所投公司产品及服务包括单克隆抗体、小分子靶向药物、抗病毒药物、ADC药物、双特异性抗体、医疗器械综合服务等。</p><p><img height="534" src="/sites/default/files/images/news/20170802-9.png" width="656" /></p><p align="justify">礼来亚洲基金（Lilly Asia Ventures）成立于2008年，专注于亚洲尤其是中国的生物医药、生物技术、医疗器械、医疗服务和动物保健领域的股权投资，同时也是中国最早的由跨国制药公司投资设立的产业基金。</p><p align="justify">礼来亚洲基金目前管理着3支美元基金和2支人民币基金，投资的阶段包括初创期、成长期及上市前期（Pre-IPO）。从2016年起，投资生物技术企业有4家。</p><p><img height="534" src="/sites/default/files/images/news/20170802-10.png" width="482" /></p><p align="justify">其中领域覆盖基因检测、抗肿瘤、抗感染，所投企业产品及服务包括生物仿制药、单克隆抗体、小分子靶向药、基因检测服务等。</p><p><img height="444" src="/sites/default/files/images/news/20170802-11.png" width="688" /></p><p align="justify">松禾资本管理有限公司是由深港产学研创业投资有限公司于2007年发起设立的专业化创业投资管理公司。目前受托管理资产超过80亿元人民币,投资超过40亿元人民币，受托管企业超过160家，有36家企业实现超额收益、成功退出。</p><p align="justify">松禾资本重点关注的领域包括移动互联网、生命科学、绿色经济、新制造新服务。</p><p align="justify">从2016年起，松禾资本投资生物技术企业有4家。</p><p align="center"><img height="534" src="/sites/default/files/images/news/20170802-11.jpg" width="404" /></p><p align="justify">上述几起投资中，领域主要覆盖基因检测。</p><p><img height="480" src="/sites/default/files/images/news/20170802-12.png" width="765" /></p><p align="justify">国投创新投资管理有限公司成立于2009年，是按照市场化要求独立运作的专业私募股权管理机构。国投创新目前直接或间接管理的基金资产规模超过500亿元，管理资金涵盖金融机构、社保基金、国有及民营资本，是国内最大的专业私募股权管理机构之一。</p><p align="justify">对生物医药领域的投资，主要是由国投创新旗下的先进制造产业投资基金进行，是由国家发改委、财政部、工业和信息化部牵头，中央财政与社会资本共同出资设立，基金规模200亿元人民币。</p><p><img height="395" src="/sites/default/files/images/news/20170802-13.jpg" width="400" /></p><p align="justify">可以看出，相比其他投资机构，国投创新更倾向于中后期的成熟项目，领域主要覆盖基因检测、抗肿瘤、免疫疾病等，所投企业产品及服务包括基因检测服务、单克隆抗体、小分子靶向药、小核酸药物等。</p><p><img height="345" src="/sites/default/files/images/news/20170802-14.png" width="745" /></p><p align="justify">雅惠精准医疗基金成立于2015年，是一家专注于基因检测全产业链投资的专业基金，目前已经在基因检测领域从实验环节到生物信息到临床服务布局了近10家企业。</p><p align="justify">虽然相比其他老牌的投资机构，雅惠精准医疗基金成立时间较短，但在基因检测领域比较活跃，据不完全统计，从2016年起，投资生物技术企业有4家。</p><p><img height="483" src="/sites/default/files/images/news/20170802-15.jpg" width="400" /></p><p align="justify">领域专注于基因检测。</p><p><img height="667" src="/sites/default/files/images/news/20170802-16.png" width="723" /></p><p align="justify">原联想投资，2001年成立，2012年联想投资更名为君联资本，核心业务定位于初创期风险投资和扩展期成长投资，兼顾钟子期项目。</p><p align="justify">目前在管美元及人民币基金总规模350亿元人民币，截止到2016年，君联资本注资企业超过300家，其中50余家企业已成功在国内或海外上市/挂牌，40余家企业通过并购退出。</p><p align="justify">主要关注领域TMT及创新消费现代服务和智能制造、医疗健康和文化体育。</p><p align="justify">从2016年起，投资生物技术企业有3家。</p><p><img height="323" src="/sites/default/files/images/news/20170802-17.jpg" width="400" /></p><p align="justify">领域覆盖肿瘤治疗、免疫疾病等，所投企业产品及服务包括细胞治疗、基因检测、单抗药物、小核酸药物等。</p><p><img height="499" src="/sites/default/files/images/news/20170802-18.png" width="705" /></p><p align="justify">苏州凯风正德投资管理有限公司（简称“凯风创投”）是元禾控股（原苏州创投集团）以市场化机制进军中国创业投资领域的开路先锋，是专注于成长早期阶段科技型项目投资的管理公司平台。凯风创投团队自2006年至今累计已独立及共同管理六支基金，管理基金规模累 计将近10亿人民币。</p><p align="justify">凯风创投投资领域：以处于初创期和成长早期阶段的高科技项目为重点，专注投资互联网、光电、芯片、装备、生物医药、新材料、新能源等领域。</p><p><img height="616" src="/sites/default/files/images/news/20170802-19.png" width="687" /></p><p align="justify">除了以上投资机构外，<strong>红杉资本、招银国际、深创投、经纬中国、幂方资本、云峰基金、高特佳、景旭创投、北极光创投、元生创投等</strong>均是关注生物医药和体外诊断领域的投资机构，想融资，就找他们。</p><p align="justify">申明：本文数据来源于网络，可能有所遗漏和错误，欢迎大家补充、批评指正。</p></div></div>    
                            </div>
        </div>
                        <div class="news-related">
            <h2 class="font-medium">More News</h2>
            <div class="view view-news view-id-news view-display-id-related hlocked view-dom-id-d5316a64ff5ac9db20cdc37f8c2f74b5">
        
  
  
      <div class="view-content">
      <div class="news-related-items">    <ul class="news-related-item">          <li class="">    <a href="/en/news/202508-QM-en"
       data-node-id="7422">
        <span class="news-type">Qiming News</span>
<span class="news-title">Qiming Venture Partners Newsletter – August 2025 </span>
<span class="news-date font-din"><strong><span class="date-display-single">10/14</span></strong> <span class="date-display-single">2025</span></span>
    </a></li>
          <li class="">    <a href="/en/news/202507-QM-en"
       data-node-id="7365">
        <span class="news-type">Qiming News</span>
<span class="news-title">Qiming Venture Partners Newsletter – July 2025 </span>
<span class="news-date font-din"><strong><span class="date-display-single">08/08</span></strong> <span class="date-display-single">2025</span></span>
    </a></li>
          <li class="">    <a href="/en/news/202506-QM-en"
       data-node-id="7333">
        <span class="news-type">Qiming News</span>
<span class="news-title">Qiming Venture Partners Newsletter – June 2025 </span>
<span class="news-date font-din"><strong><span class="date-display-single">07/08</span></strong> <span class="date-display-single">2025</span></span>
    </a></li>
          <li class="">    <a href="/en/news/202505-QM-en"
       data-node-id="7319">
        <span class="news-type">Qiming News</span>
<span class="news-title">Qiming Venture Partners Newsletter – May 2025 </span>
<span class="news-date font-din"><strong><span class="date-display-single">06/25</span></strong> <span class="date-display-single">2025</span></span>
    </a></li>
          <li class="">    <a href="/en/news/qiming-venture-partners-and-founding-managing-partner-duane-kuang-recognized-list-worlds-best"
       data-node-id="7247">
        <span class="news-type">Qiming News</span>
<span class="news-title">Qiming Venture Partners and Founding Managing Partner Duane Kuang Recognized in the List of the World&#039;s Best Investment Institutions in 2024 </span>
<span class="news-date font-din"><strong><span class="date-display-single">04/11</span></strong> <span class="date-display-single">2025</span></span>
    </a></li>
      </ul></div>    </div>
  
  
  
  
  
  
</div>        </div>
            </div>
</div></div>
            </div>
<div class="footer">
    <div class="w">
                    <div class="footer-right">
                    <div id="block-block-3" class="block block-block">

    
    <p><a class="mail" href="mailto:contactus@qimingvc.com">&nbsp;</a> <a class="linkedin" href="https://www.linkedin.com/company/qiming-venture-partners" target="_blank"><!--<span><img alt="" src="/sites/all/themes/qiming/images/linkedin.jpg" /></span>--></a> <a class="weibo" href="https://twitter.com/QimingVC" style="background-image: url(/sites/default/files/twitter-5.png);"><!--<span><img alt="" src="/sites/all/themes/qiming/images/wb.jpg" /></span>--></a> <a class="wx" href="javascript:;"> <img alt="" src="/sites/default/files/WechatIMG230130.jpeg" /><br />
WeChat</a></p>
</div>
            </div>
                            <div class="footer-t clearfix">
                    <div id="block-block-2" class="block block-block">

    
    <div class="footer-nav">
<ul>
	<li><a href="/en/team">Team</a></li>
	<li><a href="/en/portfolio">Portfolio</a></li>
	<li><a href="/en/newsroom">Newsroom</a></li>
	<li><a href="/en/about">About Us</a></li>
	<li><a href="/en/careers">Careers</a></li>
	<li><a href="/en/contact">Contact Us</a></li>
	<li><a href="/en/legal">Legal</a></li>
	<li style="display:none;"><a href="https://www.qimingvcusa.com/" target="_blank">Qiming US</a></li>
</ul>
</div>
</div>
<div id="block-block-6" class="block block-block">

    
    <div class="footer-contact">
<ul>
	<li>BP Submission: <a href="mailto:BP@qimingvc.com">BP@qimingvc.com</a></li>
	<li>Media Enquiry: <a href="mailto:PR@qimingvc.com">PR@qimingvc.com</a></li>
	<li>Feedback: <a href="mailto:contactus@qimingvc.com">contactus@qimingvc.com</a></li>
</ul>
</div>
</div>
            </div>
                <div class="footer-b font-semibold clearfix">
                <div id="block-block-4" class="block block-block">

    
    <p>©2019 Qiming Weichuang Venture Capital Management (Beijing) Co., Ltd. All Rights Reserved. <a href="/sitemap" style="display: none">网站地图</a> <a href="javascript:;" style="display: none">隐私</a>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;沪ICP备12032307号-1</p>
</div>

        </div>
    </div>
</div>

<div id="layer"></div>
    <div class="pop-nav">
        <!--
            <div class="lang-box">
                            </div>
        -->                                <div id="block-system-main-menu" class="block block-system block-menu">

    
    <ul class="menu clearfix"><li class="first leaf"><a href="/en/team">Team</a></li>
<li class="leaf"><a href="/en/portfolio">Portfolio</a></li>
<li class="leaf"><a href="/en/insights">Insights</a></li>
<li class="leaf"><a href="/en/newsroom">Newsroom</a></li>
<li class="last leaf"><a href="/en/about">About Us</a></li>
</ul></div>
                    <div id="block-menu-block-1" class="block block-menu-block">

    
    <div class="menu-block-wrapper menu-block-1 menu-name-menu-pop-menu parent-mlid-0 menu-level-1">
  <ul class="menu clearfix"><li class="first leaf menu-mlid-779"><a href="/en/careers">Careers</a></li>
<li class="leaf menu-mlid-778"><a href="/en/contact">Contact Us</a></li>
<li class="last leaf menu-mlid-780"><a href="/en/legal">Legal</a></li>
</ul></div>
</div>
        
        <a href="javascript:;" class="pop-close">&nbsp;</a>
    </div>
<!--手机端投资公司页面详情弹框-->
<div class="portfolio-pop" id="portfolioPop">
    <a href="javascript:;" class="close">&nbsp;</a>
    <div class="portfolio-pop-main">
    </div>
</div>      <script type="text/javascript" src="https://www.qimingvc.com/sites/default/files/js/js_YD9ro0PAqY25gGWrTki6TjRUG8TdokmmxjfqpNNfzVU.js"></script>
<script type="text/javascript" src="https://www.qimingvc.com/sites/default/files/js/js_0rg3W8bajVerWxJWxHfplTrhy8SCP6GaFU1_qhf43Os.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings, {"basePath":"\/","pathPrefix":"en\/","setHasJsCookie":0,"ajaxPageState":{"theme":"qiming","theme_token":"wXL9OnKFLkH2ioNG-642jZmBMcFyYukK18hw5AVanCc","js":{"misc\/jquery.js":1,"misc\/jquery-extend-3.4.0.js":1,"misc\/jquery-html-prefilter-3.5.0-backport.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/themes\/qiming\/js\/jquery.js":1,"sites\/all\/themes\/qiming\/js\/swiper.min.js":1,"sites\/all\/themes\/qiming\/js\/common.js":1,"sites\/all\/themes\/qiming\/js\/main.js":1},"css":{"modules\/system\/system.base.css":1,"modules\/system\/system.menus.css":1,"modules\/system\/system.messages.css":1,"modules\/system\/system.theme.css":1,"modules\/field\/theme\/field.css":1,"modules\/node\/node.css":1,"modules\/user\/user.css":1,"sites\/all\/modules\/views\/css\/views.css":1,"sites\/all\/modules\/ckeditor\/css\/ckeditor.css":1,"sites\/all\/modules\/media\/modules\/media_wysiwyg\/css\/media_wysiwyg.base.css":1,"sites\/all\/modules\/ctools\/css\/ctools.css":1,"sites\/all\/modules\/panels\/css\/panels.css":1,"modules\/locale\/locale.css":1,"sites\/all\/modules\/date\/date_api\/date.css":1,"sites\/all\/themes\/qiming\/css\/swiper.min.css":1,"sites\/all\/themes\/qiming\/css\/base.css":1,"sites\/all\/themes\/qiming\/css\/index.css":1,"sites\/all\/themes\/qiming\/css\/ie.css":1,"public:\/\/css_injector\/css_injector_2.css":1,"public:\/\/css_injector\/css_injector_3.css":1}},"better_exposed_filters":{"views":{"news":{"displays":{"related":{"filters":[]}}}}}});
//--><!]]>
</script>
      <!--
    <script src="/js/contact.js" type="text/javascript"></script>
  -->        </body>
</html>

